Malaysian Genomics Appoints Two New Independent Directors

KUALA LUMPUR, Aug 4 (Bernama) -- Malaysian Genomics Resource Centre Bhd has appointed Dr Chen Chaw Min and Francis Tan Leh Kiah as independent directors to its board effective from Aug 3, 2021. Chief executive officer Sasha Nordin said the company looks forward to working with both as their extensive experience and knowledge would bring significant value to the company and its long-term growth in the healthcare space. “Chen’s experience in various ministries as well as his extensive involvement in several national policy task forces and health-related councils, will be of immense value to Malaysian Genomics’ continued future expansion in providing comprehensive and diverse genomics, biopharmaceutical and healthcare services in the region. “We also look forward to working with Tan as we expand our capabilities from being a pioneer in genomics technologies to a leader in personalised and precision healthcare. His corporate experience will be valuable as we forge paths into new opportunities and emerging markets,” he said in a statement here today. Chen had previously spent more than 30 years in the civil service and contributed significantly to the nation’s COVID-19 response before retiring as the Health Ministry’s secretary-general last February. Meanwhile, Tan had before this served 20 years as a board member of the Securities Commission and was the former managing partner of Azman, Davidson & Co Advocates and Solicitors and had vast experience in corporate and tax matters. Malaysian Genomics pioneered genome sequencing and analysis in Malaysia and has recently diversified into biopharmaceutical and healthcare services including the provision of Chimeric antigen receptor T-cell (CAR T-cell) immunotherapy for cancers. -- BERNAMA